Opendata, web and dolomites

MOAB SIGNED

Miniaturised optically accessible bioreactor for drug discovery and biological research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOAB project word cloud

Explore the words cloud of the MOAB project. It provides you a very rough idea of what is the project "MOAB" about.

grant    trial    efficacy    consolidator    culture    time    demonstrations    vitro    single    96    subjected    moab    anymore    inventions    dimensions    patterned    millimetres    obsolete    patent    dish    cultivation    neurodegeneration    move    extended    fact    optically    patents    perfusion    dynamics    cancer    accommodate    populations    pharmaceutical    interactions    modified    few    context    flat    confirmed    nano    poc    actionable    pathologies    animals    organoids    billion    nichoid    valorising    accessible    added    99    size    fluid    tested    medium    continuous    chamber    suitable    lab    radically       identification    miniaturised    post    occurring    diagnostics    italian    ten    originated    ipr    infusion    original    feasibility    cog    companies    integrating    drug       perform    substrate    animal    pct    bioreactor    strategy    vivo    therapeutic    patients    market    stem    discovery    drugs    device    clinical    cell    erc    3d    cultured    frame    commercial    measured    approvals    lasts    regulatory    covered    agents   

Project "MOAB" data sheet

The following table provides information about the project.

Coordinator
POLITECNICO DI MILANO 

Organization address
address: PIAZZA LEONARDO DA VINCI 32
city: MILANO
postcode: 20133
website: www.polimi.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POLITECNICO DI MILANO IT (MILANO) coordinator 105˙000.00
2    UNIVERSITA' DEGLI STUDI DI BERGAMO IT (BERGAMO) participant 45˙000.00

Map

 Project objective

The problem that we address is that the pharmaceutical companies do not develop radically new drugs anymore, because the development process lasts ten years and costs around one billion euro. Development of a new drug is subjected to regulatory approvals following three demonstrations: lab discovery in vitro, animal testing in vivo and clinical trial on patients. This process has 99.9% overall failure, of which 96.4% because the drug efficacy measured in vitro is not confirmed in animals. In fact, the most widespread technology used to test therapeutic agents in vitro, a flat culture dish in which single cell populations are cultured and the drug to be tested is added to the culture, is obsolete. In many pathologies such as cancer and neurodegeneration, in vivo response to drugs is based on complex interactions, occurring in three-dimensions (3D) between several cell populations. To solve this problem, in the context of an ERC consolidator grant (CoG) that I currently lead, I integrated a novel nano-patterned 3D substrate for stem cell culture, called the “nichoid”, into an existing miniaturised optically accessible bioreactor (MOAB). The MOAB allows to culture 3D organoids of few millimetres in size, under continuous perfusion of the culture medium, infusion of the drug to be tested and diagnostics of cell response both in real time and also post-cultivation. Both the original inventions (the nichoid and the MOAB) are covered by Italian patents originated in the frame of the CoG project and already extended as PCT. The goal of this PoC proposal is to perform a technical and commercial feasibility to move to the market the MOAB device integrating the nichoid-patterned substrate. I will characterize the fluid-dynamics of the bioreactor chamber that has been modified to accommodate the nichoid substrate. Also, I will set a market assessment and an actionable IPR strategy with identification of a suitable exploitation strategy for valorising the patent/know how.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

CARBOFLOW (2020)

Streamlined carbon dioxide conversion in ionic liquids – a platform strategy for modern carbonylation chemistry

Read More  

SUBMODULAR (2019)

The Power of Randomness and Continuity in Submodular Optimization

Read More